Characteristics and Outcomes of Patients With Hematological Malignancies
NCT06402175 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2024-06-05
Summary
The pattern of hematological malignancies (HMs) in developing countries and developed countries differs. Among the different types of cancers, leukemia, lymphoma, and multiple myeloma appear to have greatly increased in frequency.
Conditions
- Haematologic Neoplasm
Interventions
- OTHER
-
follow up
follow up
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-07-01
- Primary Completion
- 2027-03-01
- Completion
- 2027-04-01
More Related Trials
-
Clinical, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Hematologic Cancer
NCT00039676 ·Status: ACTIVE_NOT_RECRUITING
-
Clinico-hematological and Molecular Characteristics of Chronic Lymphocytic Leukemia Patients
NCT07162532 ·Status: NOT_YET_RECRUITING
-
The Pathogenesis and Prognostic Factors of Lymphoma
NCT06203652 ·Status: RECRUITING
-
Pathogenesis of Hematologic Malignancies
NCT01728402 ·Status: ENROLLING_BY_INVITATION
-
Clinical Cohort of Lymphoma Patients in Malawi
NCT02835911 ·Status: RECRUITING
-
Association Between Multiple Coagulation-related Factors and Lymph Node Metastasis in Patients With Gastric Cancer: A Retrospective Cohort Study
NCT05592925 ·Status: UNKNOWN
-
Studying Common Genetic Mutations Related to Mucositis in Patients With Multiple Myeloma Receiving High-Dose Melphalan
NCT00602147 ·Status: TERMINATED
-
Data Collection of Standard Care and Evaluation of NHLBI Patients and Donors
NCT04450927 ·Status: ENROLLING_BY_INVITATION
-
Screening Gene Mutations in Myeloid Cancers by Next Generation Sequencing to Improve Treatment Results
NCT04060485 ·Status: UNKNOWN
-
Oral Complications in Hematological Malignancies
NCT05758207 ·Status: UNKNOWN
-
Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile
NCT01454297 ·Status: COMPLETED
-
The Microbiome in Blood Cancer and HLH
NCT06734624 ·Status: NOT_YET_RECRUITING
-
Integrated Multiomics and Multilevel Characterization of Haematological Disorders and Malignancies
NCT04298892 ·Status: UNKNOWN
-
Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome
NCT02269592 ·Status: RECRUITING
-
Development of a Research Infrastructure for Understanding and Addressing Multiple Myeloma Disparities
NCT04314752 ·Status: RECRUITING
-
Molecular Disease Profile of Hematological Malignancies
NCT02459743 ·Status: UNKNOWN
-
Notch 1 Mutation in Chronic Lymphocytic Leukemia and Non-Hodgkin's Lymphoma Patient
NCT07157579 ·Status: NOT_YET_RECRUITING
-
Effectiveness of Circulating DNA for Predicting the Relapse and Overall Survival in NHL Patients
NCT03079947 ·Status: UNKNOWN
-
Analysis of Circulating Tumor Markers in Blood
NCT04025541 ·Status: RECRUITING ·Phase: NA
-
Could Ki-67 be Used as a Diagnostic or Prognostic Marker in Hemato-oncological Diagnostics?
NCT04517175 ·Status: UNKNOWN
-
Identification of Marker of Primary or Acquired Resistance to Anti Tumorous Treatment
NCT02105168 ·Status: UNKNOWN ·Phase: NA
-
Detection of IDH2 Mutations and Monitoring Molecular Residual Disease in Patients With AML
NCT03537560 ·Status: COMPLETED
-
The American Society of Hematology (ASH) Research Registry: A Multicenter Research Registry of Patients With Hematologic Disease
NCT03535220 ·Status: UNKNOWN
-
Target Gene Sequencing for Advanced Stage, Relapsed or Refractory Natural Killer/T-cell Lymphoma
NCT04509804 ·Status: COMPLETED
-
Early Assessment of Lymphoma Treatment Response Using Phased Variant Analysis With Next-Generation Sequencing
NCT06550427 ·Status: RECRUITING